You just read:

Veloce BioPharma Announces Positive Phase 2b Study Results for VBP-926 (Topical Povidone-Iodine in a Novel Non-Aqueous Vehicle) in Subjects with Chemotherapy-Associated Paronychia

News provided by

Veloce BioPharma, LLC

03 Oct, 2018, 06:10 BST